SI3085381T1 - Orodispersible desmopressin to increase the initial sleep period without disturbing the nostrils - Google Patents

Orodispersible desmopressin to increase the initial sleep period without disturbing the nostrils Download PDF

Info

Publication number
SI3085381T1
SI3085381T1 SI200931838T SI200931838T SI3085381T1 SI 3085381 T1 SI3085381 T1 SI 3085381T1 SI 200931838 T SI200931838 T SI 200931838T SI 200931838 T SI200931838 T SI 200931838T SI 3085381 T1 SI3085381 T1 SI 3085381T1
Authority
SI
Slovenia
Prior art keywords
composition
desmopressin
use according
dose
treatment
Prior art date
Application number
SI200931838T
Other languages
English (en)
Slovenian (sl)
Inventor
Bjarke Mirner Klein
Jens Peter Norgaard
Brad Shumel
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41100519&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3085381(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of SI3085381T1 publication Critical patent/SI3085381T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
SI200931838T 2008-05-21 2009-05-21 Orodispersible desmopressin to increase the initial sleep period without disturbing the nostrils SI3085381T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5512008P 2008-05-21 2008-05-21
EP16165875.2A EP3085381B1 (en) 2008-05-21 2009-05-21 Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia

Publications (1)

Publication Number Publication Date
SI3085381T1 true SI3085381T1 (en) 2018-06-29

Family

ID=41100519

Family Applications (4)

Application Number Title Priority Date Filing Date
SI200931838T SI3085381T1 (en) 2008-05-21 2009-05-21 Orodispersible desmopressin to increase the initial sleep period without disturbing the nostrils
SI200931494A SI2712622T1 (sl) 2008-05-21 2009-05-21 Orodisperzibilni dezmopresin za povečanje začetnega obdobja spanja nemotenega z nokturijo
SI200932000T SI3225250T1 (sl) 2008-05-21 2009-05-21 Orodisperzibilen dezmopresin za podaljšanje začetnega obdobja spanja, ki ga ne moti nokturija
SI200931912T SI3225249T1 (sl) 2008-05-21 2009-05-21 Orodisperzibilen dezmopresin za povečanje začetnega obdobja spanja, ki ga ne moti nokturija

Family Applications After (3)

Application Number Title Priority Date Filing Date
SI200931494A SI2712622T1 (sl) 2008-05-21 2009-05-21 Orodisperzibilni dezmopresin za povečanje začetnega obdobja spanja nemotenega z nokturijo
SI200932000T SI3225250T1 (sl) 2008-05-21 2009-05-21 Orodisperzibilen dezmopresin za podaljšanje začetnega obdobja spanja, ki ga ne moti nokturija
SI200931912T SI3225249T1 (sl) 2008-05-21 2009-05-21 Orodisperzibilen dezmopresin za povečanje začetnega obdobja spanja, ki ga ne moti nokturija

Country Status (16)

Country Link
US (2) US9974826B2 (OSRAM)
EP (5) EP2712622B1 (OSRAM)
JP (5) JP5767103B2 (OSRAM)
CA (1) CA2724653A1 (OSRAM)
DK (5) DK2296686T4 (OSRAM)
ES (5) ES2710454T3 (OSRAM)
HR (4) HRP20161066T1 (OSRAM)
HU (5) HUE030409T2 (OSRAM)
LT (5) LT2712622T (OSRAM)
LU (1) LUC00015I2 (OSRAM)
NO (3) NO3085381T3 (OSRAM)
PL (5) PL2712622T3 (OSRAM)
PT (5) PT3085381T (OSRAM)
SI (4) SI3085381T1 (OSRAM)
TR (2) TR201807224T4 (OSRAM)
WO (1) WO2009143356A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100286045A1 (en) * 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
NO3085381T3 (OSRAM) * 2008-05-21 2018-09-15
WO2015063602A1 (en) * 2013-10-29 2015-05-07 Ferring B.V. Desmopressin and blood glucose
EP3868215A4 (en) * 2018-10-16 2022-07-27 Nippon Chemiphar Co., Ltd. SLEEP QUALITY IMPROVING AGENT
KR20210078500A (ko) * 2018-10-17 2021-06-28 닛뽕 케미파 가부시키가이샤 야간 다뇨의 치료 또는 예방제
US20230149330A1 (en) * 2020-04-14 2023-05-18 Nippon Chemiphar Co., Ltd. Sleep quality improver
CA3198547A1 (en) 2020-11-16 2022-05-19 Mark RIDALL Rapidly infusing platform and compositions for therapeutic treatment in humans
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4285858A (en) * 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4263283A (en) * 1980-05-16 1981-04-21 Ferring Pharmaceuticals, Inc. Method for prophylaxis and/or treatment of sickle cell disease
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
DE3275121D1 (en) 1981-12-11 1987-02-19 Wyeth John & Brother Ltd Process for preparing solid shaped articles
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
SE8306367L (sv) 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4878892A (en) 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4783450A (en) 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
DK365389D0 (da) 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
TW279133B (OSRAM) 1990-12-13 1996-06-21 Elan Med Tech
US5527288A (en) * 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
SE9101022D0 (sv) * 1991-01-09 1991-04-08 Paal Svedman Medicinsk suganordning
US6746678B1 (en) * 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
AU653026B2 (en) 1991-06-07 1994-09-15 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide-containing pharmaceutical composition
IL102857A (en) 1991-08-26 1997-02-18 Abbott Lab Compositions for the sublingual or buccal administration of therapeutic agents which are degraded upon oral administration
NZ246091A (en) 1991-12-24 1995-08-28 Yamanouchi Pharma Co Ltd Intrabuccally disintegrating preparation containing an active ingredient, agar, and lactose and/or mannitol
US5298256A (en) * 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5534496A (en) * 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
CA2090738C (en) 1993-02-24 1996-05-21 Hema-Quebec Use of paf
SE9300937L (sv) * 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
US5434121A (en) * 1993-03-25 1995-07-18 Mitsui Toatsu Chemicals, Incorporated Variety of Drechslera monoceras, weed control compositions containing the same as an effective ingredient and weed control methods using the same
SE501677C2 (sv) 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
US5985835A (en) 1993-12-23 1999-11-16 Ferring B.V. Desmopressin for nocturia, incontinence and enuresis
US5674850A (en) 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
EP0710243B1 (en) * 1993-06-29 2000-06-14 Ferring B.V. Synthesis of cyclic peptides
DE69427820T2 (de) 1993-06-29 2001-11-08 Ferring B.V., Hoofdorp Zusammensetzungen zur nasalen verabreichung von desmopressin
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5707648A (en) * 1993-11-17 1998-01-13 Lds Technologies, Inc. Transparent liquid for encapsulated drug delivery
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
JP2551742B2 (ja) * 1994-05-23 1996-11-06 三星電機株式会社 医薬品投与用皮膚傷形成装置
DE4424800A1 (de) * 1994-07-14 1996-01-18 Philips Patentverwaltung Schaltungsanordnung zum Liefern von Speisespannungen
SE518619C2 (sv) * 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
GB9502879D0 (en) * 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
IL113459A (en) * 1995-04-23 2000-07-16 Electromagnetic Bracing System Electrophoretic cuff apparatus
US5843016A (en) 1996-03-18 1998-12-01 Physion S.R.L. Electromotive drug administration for treatment of acute urinary outflow obstruction
TW411277B (en) 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
DE69719761T2 (de) * 1996-06-18 2003-12-18 Alza Corp., Palo Alto Vorrichtung zur verbesserung der transdermalen verabreichung von medikamenten oder der abnahme von körperflüssigkeiten
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
FR2758195B1 (fr) 1997-01-09 1999-02-26 Sgs Thomson Microelectronics Coprocesseur d'arithmetique modulaire comprenant deux circuits de multiplication operant en parallele
US5821230A (en) 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US6194407B1 (en) * 1997-07-30 2001-02-27 American Home Products Corporation Tricyclic pyrido vasopressin agonists
US5932745A (en) * 1997-07-30 1999-08-03 American Home Products Corporation Process for converting propargylic amine-N-oxides to enaminones
US6511974B1 (en) * 1997-07-30 2003-01-28 Wyeth Tricyclic vasopressin agonists
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US7153845B2 (en) 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6322532B1 (en) 1998-06-24 2001-11-27 3M Innovative Properties Company Sonophoresis method and apparatus
US6090803A (en) * 1998-07-24 2000-07-18 American Home Products Corporation Tricyclic vasopressin agonists
US7138393B2 (en) * 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US6148232A (en) 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
GB9827292D0 (en) 1998-12-12 1999-02-03 Univ Strathclyde Freeze drying
US6406455B1 (en) * 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US20060025387A1 (en) * 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
GB9901819D0 (en) 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
US6235900B1 (en) * 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
US6620807B1 (en) 1999-02-04 2003-09-16 Wyeth Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
US6344451B1 (en) * 1999-02-04 2002-02-05 American Home Products Pyrrolobenzodiazepine carboxyamide vasopressin agonists
JP4435424B2 (ja) 1999-02-15 2010-03-17 大日本住友製薬株式会社 口腔内で速やかに崩壊する錠剤
JP2002537031A (ja) * 1999-02-18 2002-11-05 バイオバルブ テクノロジーズ インコーポレイテッド 電気活性な細孔
AR014640A1 (es) * 1999-02-23 2001-03-28 Univ Nac Quilmes UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7060708B2 (en) * 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6210699B1 (en) 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB2355454A (en) 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
US6558695B2 (en) * 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
EP1296730B2 (en) 2000-01-07 2014-07-30 Valeritas, Inc. Injection device
US20070032410A1 (en) * 2000-01-11 2007-02-08 Atossa Healthcare, Inc. Compositions and methods for the treatment of psychiatric disorders
AT409081B (de) * 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
US6348486B1 (en) * 2000-10-17 2002-02-19 American Home Products Corporation Methods for modulating bladder function
EP1333880B1 (en) 2000-10-26 2009-04-15 Alza Corporation Transdermal drug delivery devices having coated microprotrusions
WO2002055128A2 (en) * 2000-11-30 2002-07-18 Biovalve Technologies Inc Fluid delivery and measurement systems and methods
EP1339442A4 (en) 2000-11-30 2006-12-27 Biovalve Technologies Inc INJECTION SYSTEMS
WO2002064193A2 (en) 2000-12-14 2002-08-22 Georgia Tech Research Corporation Microneedle devices and production thereof
WO2002050584A2 (en) * 2000-12-21 2002-06-27 Biovalve Technologies, Inc. Microneedle array systems
PT1381352E (pt) 2001-03-16 2007-07-27 Alza Corp Adesivo transdérmico para administração de fenantil
US7022699B2 (en) * 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
DK1381370T3 (da) * 2001-04-12 2007-05-21 Wyeth Corp N-Biphenylcarbonyl- og N-phenylpyridylcarbonyl-substituerede bi- og tricykliske azepiner og diazepiner som vasopressin-agonister
DK1381608T3 (da) * 2001-04-12 2008-02-04 Wyeth Corp Cyclohexylphenylvasopressinagonister
GB2391480B (en) * 2002-08-05 2007-02-28 Caretek Medical Ltd Drug delivery system
US7615234B2 (en) * 2001-09-11 2009-11-10 Glide Pharmaceutical Technologies Limited Drug delivery technology
HRP20040250A2 (en) 2001-09-13 2005-02-28 Kissei Pharmaceutical Co.Ltd. Crystals of hydroxynorephedrine derivative
US6723077B2 (en) * 2001-09-28 2004-04-20 Hewlett-Packard Development Company, L.P. Cutaneous administration system
US6893655B2 (en) * 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
CA2464069A1 (en) * 2001-11-16 2003-05-22 Hiroyuki Koshio 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003094886A2 (en) 2002-05-07 2003-11-20 Ferring Bv Desmopressin in an orodispersible dosage form
US6945952B2 (en) * 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
EP1590033A2 (en) * 2002-09-30 2005-11-02 Alza Corporation Drug delivery device having coated microprojections incorporating vasoconstrictors
BR0314754A (pt) * 2002-10-09 2005-07-26 Toray Industries Agente terapêutico ou profilático para a frequência urinária ou a incontinência urinária ou um seu sal de adição de ácido farmaceuticamente aceitável, método para terapia ou profilaxia para frequência urinária, urgência urinária ou incontinência urinária, uso de um derivado de morfina tendo um grupo heterocìclico contendo nitrogênio ou de um seu sal de adição de ácido farmaceuticamente aceitável, derivado de morfina ou um seu sal de adição de ácido farmaceuticamente aceitável, produto farmacêutico, e, composição farmacêutica
US7383084B2 (en) * 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
EP1428526A1 (en) 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
DE10259934B3 (de) * 2002-12-20 2004-10-14 H.C. Starck Gmbh Verfahren zur Herstellung von Formteilen aus Niob oder Tantal durch elektrochemisches Ätzen und so erhältliche Formteile
AR042815A1 (es) * 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
US7183271B2 (en) * 2003-04-28 2007-02-27 Astellas Pharma Inc. 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
US20060193825A1 (en) * 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
WO2005004729A1 (en) 2003-06-30 2005-01-20 Alza Corporation Method for coating skin piercing microprojections
PT1500390E (pt) * 2003-07-25 2005-10-31 Ferring Bv Composicao farmaceutica como forma de dosagem solida e metodo de producao
CN1826099B (zh) 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
US6930932B2 (en) * 2003-08-27 2005-08-16 Hewlett-Packard Development Company, L.P. Data signal reception latch control using clock aligned relative to strobe signal
JP2007508914A (ja) 2003-10-24 2007-04-12 アルザ・コーポレーシヨン 経皮薬剤送達を促進するための装置及び方法
US20050106226A1 (en) * 2003-10-24 2005-05-19 Cormier Michel J. Pretreatment method and system for enhancing transdermal drug delivery
EP1680154B1 (en) * 2003-10-31 2012-01-04 ALZA Corporation Self-actuating applicator for microprojection array
JP5596252B2 (ja) * 2003-11-10 2014-09-24 アラーガン、インコーポレイテッド 低用量デスモプレシンを含有する医薬組成物
DE60305043T2 (de) 2003-11-13 2006-11-30 Ferring B.V. Blisterverpackung und feste Dosierungsform enthaltend Desmopressin
EP1550439B1 (en) 2003-12-29 2006-03-08 Ferring B.V. Method for preparing a solid dosage form of desmopressin
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
MXPA06007832A (es) * 2004-01-09 2007-01-26 Johnson & Johnson Metodo y sistema de suministro de agente transdermico asistido por frecuencia.
HRP20160455T1 (hr) * 2004-09-09 2016-07-15 Yeda Research And Development Co., Ltd. Smjese polipeptida, sastavi koji ih sadrže i postupci za njihovu pripremu, te njihove primjene
US7097776B2 (en) * 2004-10-22 2006-08-29 Hewlett-Packard Development Company, L.P. Method of fabricating microneedles
US20060093658A1 (en) * 2004-10-26 2006-05-04 Gayatri Sathyan Apparatus and method for transdermal delivery of desmopressin
CN100339081C (zh) 2004-11-10 2007-09-26 范敏华 一种氯雷他定口腔崩解片剂的制备方法
US7180274B2 (en) * 2004-12-10 2007-02-20 Aimtron Technology Corp. Switching voltage regulator operating without a discontinuous mode
CA2604759A1 (en) 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
MX2007012883A (es) 2005-04-22 2007-12-10 Wyeth Corp Derivados de dihidrobenzofurano y usos de los mismos.
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
KR20080009295A (ko) 2005-04-22 2008-01-28 와이어쓰 벤조디옥산 및 벤조디옥솔란 유도체 및 이의 용도
TW200716595A (en) 2005-04-22 2007-05-01 Wyeth Corp Chromane and chromene derivatives and uses thereof
US7368477B2 (en) 2005-04-22 2008-05-06 Wyeth Benzofuranyl alkanamine derivatives and uses thereof
MX2007013064A (es) 2005-04-24 2008-01-16 Wyeth Corp Metodo para modular la funcion de la vejiga.
CA2612005C (en) 2005-06-17 2013-10-29 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
US20080195035A1 (en) 2005-06-24 2008-08-14 Frederickson Franklyn L Collapsible Patch and Method of Application
WO2007083323A2 (en) 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
WO2007098945A2 (en) 2006-03-02 2007-09-07 Ferring International Center S.A. Stable solid dosage form comprising desmopressin
WO2007127976A2 (en) 2006-05-01 2007-11-08 Georgia Tech Research Corporation Particle based molding
AU2008283929B2 (en) 2007-08-06 2013-10-10 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
NO3085381T3 (OSRAM) * 2008-05-21 2018-09-15

Also Published As

Publication number Publication date
EP3085381B1 (en) 2018-04-18
JP2018035198A (ja) 2018-03-08
US20090291880A1 (en) 2009-11-26
SI3225249T1 (sl) 2019-02-28
TR201807224T4 (tr) 2018-06-21
US9974826B2 (en) 2018-05-22
DK2296686T3 (da) 2014-05-12
LUC00015I1 (OSRAM) 2017-04-19
HRP20190114T1 (hr) 2019-03-08
US20180250357A1 (en) 2018-09-06
PL2296686T5 (pl) 2018-06-29
LT3225250T (lt) 2019-11-11
ES2756706T3 (es) 2020-04-27
JP2011520980A (ja) 2011-07-21
PT3225249T (pt) 2019-01-17
PL2296686T3 (pl) 2014-07-31
HUE030409T2 (en) 2017-05-29
PT2712622T (pt) 2016-10-13
PL3225249T3 (pl) 2019-05-31
PT2296686E (pt) 2014-05-23
ES2462465T3 (es) 2014-05-22
LT2712622T (lt) 2016-09-26
EP3085381A1 (en) 2016-10-26
JP6506821B2 (ja) 2019-04-24
LTC2712622I2 (lt) 2020-02-10
EP2296686A1 (en) 2011-03-23
SI2712622T1 (sl) 2016-10-28
EP3225249B1 (en) 2018-11-07
ES2462465T5 (es) 2018-02-28
ES2677548T3 (es) 2018-08-03
EP3225249A1 (en) 2017-10-04
JP6001121B2 (ja) 2016-10-05
EP2712622B1 (en) 2016-07-13
NO2019021I1 (no) 2019-04-30
HRP20191854T1 (hr) 2019-12-27
PT3225250T (pt) 2019-10-15
NO3085381T3 (OSRAM) 2018-09-15
EP3225250B1 (en) 2019-08-21
HUE046050T2 (hu) 2020-01-28
JP6258424B2 (ja) 2018-01-10
PL2712622T3 (pl) 2017-01-31
ES2710454T3 (es) 2019-04-25
DK2296686T4 (en) 2018-01-02
JP6836618B2 (ja) 2021-03-03
LT3225249T (lt) 2019-01-10
HUS1900024I1 (hu) 2019-05-28
HUE039013T2 (hu) 2018-12-28
HUE041370T2 (hu) 2019-05-28
JP2015120761A (ja) 2015-07-02
DK3225250T3 (da) 2019-11-04
PT3085381T (pt) 2018-05-18
LT3085381T (lt) 2018-06-11
EP3225250A1 (en) 2017-10-04
LTPA2017001I1 (lt) 2017-02-10
CA2724653A1 (en) 2009-11-26
ES2596435T3 (es) 2017-01-09
JP2016196514A (ja) 2016-11-24
LUC00015I2 (OSRAM) 2017-06-19
PL3085381T3 (pl) 2018-09-28
EP2296686B1 (en) 2014-02-12
HUE039013T4 (hu) 2019-08-28
EP2712622A1 (en) 2014-04-02
EP2296686B2 (en) 2017-11-01
JP5767103B2 (ja) 2015-08-19
DK3225249T3 (en) 2019-02-25
PL3225250T3 (pl) 2020-02-28
HRP20180774T1 (hr) 2018-08-10
SI3225250T1 (sl) 2019-11-29
WO2009143356A1 (en) 2009-11-26
JP2019123739A (ja) 2019-07-25
DK2712622T3 (en) 2016-09-12
NO2296686T3 (OSRAM) 2014-07-12
TR201819189T4 (tr) 2019-01-21
HRP20161066T1 (hr) 2016-10-21
DK3085381T3 (en) 2018-05-28

Similar Documents

Publication Publication Date Title
SI3085381T1 (en) Orodispersible desmopressin to increase the initial sleep period without disturbing the nostrils
MX2009012485A (es) Formulacion oral de nicotina amortiguada con aminoacidos.
HRP20181026T1 (hr) Dugodjelujuće formulacije inzulina
EP1786400A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE CONTROLLED RELEASE OF BIOLOGICAL ACTIVE SUBSTANCES
NZ609719A (en) Pharmaceutical composition
NZ702799A (en) Methods and compositions for cns delivery of arylsulfatase a
PH12013500923A1 (en) Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
JP2011520980A5 (OSRAM)
WO2014183018A3 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES THROUGH INHIBITING TGF-β ACTIVITY
CA2829832C (en) Use of a sprayable composition comprising ambroxol
MY163107A (en) Pharmaceutical composition for the treatment of bladder disorders
MD3422G2 (ro) Procedeu de profilaxie şi tratament al knemidocoptozei galinaceelor
ES2252651T3 (es) Composicion para la desintoxicacion del tabaco o para la desintoxicacion de alcohol.
Yilmaz et al. The effects of combined phytoestrogen administration on growth performance, sex differentiation and body composition of sharp tooth catfish Clarias gariepinus (Burchell, 1822)
WO2010131909A3 (ko) 호흡기 염증성 질환의 치료 또는 예방을 위한 호흡기내 투여용 약학 제제 및 상기 질환의 치료 또는 예방 방법
MX2021012568A (es) Preparacion de combinacion farmaceutica que comprende ezetimiba y losartan.
MX2011013113A (es) Soluciones de inyeccion e infusion de diacetato de ipamorelin.
JP4830109B2 (ja) 鶏の暑熱ストレス又は熱死の抑制
JP2024178940A (ja) 遺伝子発現抑制剤及び該遺伝子発現抑制用組成物
RU2016111112A (ru) Композиции и способы для лечения патологических состояний носа
PH12015502560B1 (en) Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease
RU2010102484A (ru) Способ применения маточного молочка для увеличения фертильности
RU2008151796A (ru) Способ профилактики желудочно-кишечных заболеваний у поросят-отъемышей
RU2009102606A (ru) Способ выращивания птицы
RU2008152690A (ru) Способ лечения животных при послеродовом эндометрите